Q3 2024 Earnings Call Transcript November 4, 2024 Medifast, Inc. beats earnings expectations. Reported EPS is $0.1029, ...

Starting with those who want to use GLP-1 medications at the core of their weight-loss efforts. We've expanded training for our independent OPTAVIA coaches to better equip them to help customers ...

Despite a significant revenue drop, Medifast Inc (MED) focuses on innovation and strategic marketing to counteract market pressures and competition.

Medifast ( (MED) ) has released its Q3 earnings. Here is a breakdown of the information Medifast presented to its investors. Medifast (NYSE: ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.

Unbelievable markdowns. A simple online search for semaglutide, the active ingredient in Ozempic or Wegovy, can lead consumers down a rabbit hole of seemingly reputable online pharmacies in search of ...

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

A new study shows that Ozempic may help ease arthritis knee pain in people with obesity. Here's what to know about the study and whether semaglutide can truly help reduce knee pain, according to ...